HEcoPerMed Modeling Case Studies for Validation of Methodological Guidance
This method tests how well a set of recommendations for economic evaluations in personalized medicine works in real-world examples. Three different disease models were used to check which recommendations were most important and how they affect decisions.
At a glance
Use when
Developing or evaluating economic models for personalized medicine interventions; validating methodological guidance; improving transparency in model design and decision justification
Avoid when
When guidance recommendations are not available or applicable; when models lack sufficient documentation to trace recommendation impact
Inputs
Health economic models in personalized medicine; HEcoPerMed methodological guidance (23 recommendations)
Outputs
Assessment of guidance applicability; identification of critical recommendations; lessons on implementation challenges and decision justification
How it works
A validation framework developed within the HEcoPerMed project to assess the applicability and impact of its methodological guidance for economic evaluations in personalized medicine. The guidance was tested across three health economic modeling case studies in different therapeutic areas. Twenty out of twenty-three recommendations were implemented, with varying levels of adoption across studies. The framework identifies which recommendations critically influence model outcomes and supports structured decision justification in economic analyses of personalized interventions.
- Project
- HEcoPerMed
- Funding
- Horizon 2020
- Project status
- Completed 2022
- HTA domains
- Clinical Effectiveness, Costs & Economic Evaluation, Organisational aspects
- Categories
- Cost-effectiveness ModellingHeterogeneityModel ValidationReporting Standards & Best Practice
- Assumptions
- The methodological guidance is comprehensive and applicable across therapeutic areas; modelers can implement recommendations consistently; model structure allows for tracing the impact of specific recommendations on outcomes
- Strengths
- Demonstrates real-world applicability of methodological guidance,Highlights recommendations with critical impact on conclusions,Supports transparent and justifiable decision-making in modeling
- Limitations
- Only three case studies were used, limiting generalizability,Not all recommendations were implemented in every model,Therapeutic area specificity may affect transferability
- Also known as
- HEcoPerMed Validation Framework, HEcoPerMed Modeling Case Studies, HEcoPerMed Guidance Validation
Questions this answers
- › Which recommendations from the HEcoPerMed guidance are most applicable in practice?
- › How do specific methodological choices affect economic evaluation outcomes in personalized medicine?
- › What role do individual recommendations play in shaping final conclusions of health economic models?
- › How can methodological guidance improve transparency and justification in modeling for personalized interventions?
- › Which aspects of economic evaluation in personalized medicine require prioritization during analysis?
- › How can guidance be operationalized across diverse therapeutic areas?
References & sources
Similar by meaning
- HEcoPerMed Guidance for Harmonisation and Improvement of Economic Evaluations in Personalised Medicine
- Guidance for good health economic modelling practices in personalised medicines
- Model Parameter Estimation and Uncertainty
- heemod
- Conceptualizing a Model (ISPOR-SMDM Modeling Good Research Practices Task Force-2)
Beta record. Based on the original catalogue summary; primary-source enrichment pending.